PYPL vs ZVRA · P/E 7.9, rev $33.17B vs P/E 6.3, rev $75.9M
PayPal Holdings Inc (PYPL) versus Zevra Therapeutics Inc. (ZVRA) — a side-by-side from cached financials, not a winner call.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Enrique J. Lores.
Zevra Therapeutics Inc. (ZVRA) is a biotechnology company listed on NASDAQ.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Latest reported ZVRA revenue for 2026-06-30 was $75.9M. Net income was $46.6M. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
PYPL currently screens at market cap $37.12B and trailing P/E 7.9. ZVRA currently screens at market cap $745.4M and trailing P/E 6.3.
Not investment advice. Open the PYPL and ZVRA stock pages for the full models.
Not investment advice.